Osteoporosis and fractures in women: the burden of disease

References

• NIH Consensus Developmemt Panel on Osteoporosis Prevention, Diagnosis and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285(6):785–795.
   PubMed Web of Science ®Google Scholar
• Lorentzon M, Cummings SR. Osteoporosis: the evolution of a diagnosis. J Intern Med. 2015;277(6):650–661.
   PubMed Web of Science ®Google Scholar
• Cheng XG, Lowet G, Boonen S, et al. Assessment of the strength of proximal femur in vitro: relationship to femoral bone mineral density and femoral geometry. Bone. 1997;20(3):213–218.
   PubMed Web of Science ®Google Scholar
• Johnell O, Kanis JA, Oden A, et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005;20(7):1185–1194.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Melton LJ, 3rd, Christiansen C, et al. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9(8):1137–1141.
   PubMed Web of Science ®Google Scholar
• Kanis JA, McCloskey EV, Johansson H, et al. A reference standard for the description of osteoporosis. Bone. 2008;42(3):467–475.
   PubMed Web of Science ®Google Scholar
• Khosla S, Melton LJ, 3rd, Riggs BL. The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed? J Bone Miner Res. 2011;26(3):441–451.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Oden A, Johnell O, et al. The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int. 2001;12(5):417–427.
   PubMed Web of Science ®Google Scholar
• Warriner AH, Patkar NM, Curtis JR, et al. Which fractures are most attributable to osteoporosis? J Clin Epidemiol. 2011;64(1):46–53.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johnell O, Oden A, et al. Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int. 2000;11(8):669–674.
   PubMed Web of Science ®Google Scholar
• Gerdhem P. Osteoporosis and fragility fractures: vertebral fractures. Best Pract Res Clin Rheumatol. 2013;27(6):743–755.
   PubMed Web of Science ®Google Scholar
• Bliuc D, Nguyen TV, Eisman JA, et al. The impact of nonhip nonvertebral fractures in elderly women and men. J Clin Endocrinol Metab. 2014;99(2):415–443.
   PubMed Web of Science ®Google Scholar
• Johnell O, Kanis JA, Oden A, et al. Mortality after osteoporotic fractures. Osteoporos Int. 2004;15(1):38–42.
   PubMed Web of Science ®Google Scholar
• Cooper C, Campion G, Melton LJ. 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2(6):285–289.
   PubMed Web of Science ®Google Scholar
• Kanis JA. Assessment of osteoporosis at the primary health care level. In WHO Scientific Group, editor. WHO scientific group technical report. Sheffield: World Health Organization; 2007. p. 103.
   Google Scholar
• Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726–1733.
   PubMed Web of Science ®Google Scholar
• Jordan KM, Cooper C. Epidemiology of osteoporosis. Best Pract Res Clin Rheumatol. 2002;16(5):795–806.
   PubMed Web of Science ®Google Scholar
• Dennison EM, Sayer AA, Cooper C. Epidemiology of sarcopenia and insight into possible therapeutic targets. Nat Rev Rheumatol. 2017;13(6):340–347.
   PubMed Web of Science ®Google Scholar
• Sambrook P, Cooper C. Osteoporosis. Lancet. 2006;367(9527):2010–2018.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Oden A, McCloskey EV, et al. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012;23(9):2239–2256.
   PubMed Web of Science ®Google Scholar
• Pisani P, Renna MD, Conversano F, et al. Major osteoporotic fragility fractures: risk factor updates and societal impact. World J Orthop. 2016;7(3):171–181.
   PubMed Web of Science ®Google Scholar
• Jakobsen A, Laurberg P, Vestergaard P, et al. Clinical risk factors for osteoporosis are common among elderly people in Nuuk, Greenland. Int J Circumpolar Health. 2013;72:19596.
   PubMed Web of Science ®Google Scholar
• Borgstrom F, Karlsson L, Ortsater G, et al. Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos. 2020;15(1):59.
   PubMed Web of Science ®Google Scholar
• Hippisley-Cox J, Coupland C, Robson J, et al. Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database. BMJ. 2010;341:c6624–c6624.
   PubMedGoogle Scholar
• Johansson L, Sundh D, Nilsson M, et al. Vertebral fractures and their association with health-related quality of life, back pain and physical function in older women. Osteoporos Int. 2018;29(1):89–99.
   PubMed Web of Science ®Google Scholar
• Sernbo I, Johnell O. Consequences of a hip fracture: a prospective study over 1 year. Osteoporos Int. 1993;3(3):148–153.
   PubMed Web of Science ®Google Scholar
• Adib Hajbaghery M, Abbasinia M. Quality of life of the elderly after hip fracture surgery: a case-control study. J Caring Sci. 2013;2(1):53–59.
   PubMedGoogle Scholar
• Center JR, Nguyen TV, Schneider D, et al. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999;353(9156):878–882.
   PubMed Web of Science ®Google Scholar
• Johansen A, Mansor M, Beck S, et al. Outcome following hip fracture: long term mortality and post-discharge residence. Osteoporos Int. 2012;23:S545–S545.
   Web of Science ®Google Scholar
• World Health Organization. Metrics: disability-adjusted life years (DALY). WHO; 2018 [cited 2017 Oct 12]. Available from: http://www.who.int/healthinfo/global_burden_disease/metrics_daly/en/
   Google Scholar
• GBD compare data visualization: Institute for Health Metrics and Evaluation (IHME); 2016. Available from: https://vizhub.healthdata.org/gbdcompare/.
   Google Scholar
• Melton LJ, 3rd, Gabriel SE, Crowson CS, et al. Cost-equivalence of different osteoporotic fractures. Osteoporos Int. 2003;14(5):383–388.
   PubMed Web of Science ®Google Scholar
• Williamson S, Landeiro F, McConnell T, et al. Costs of fragility hip fractures globally: a systematic review and meta-regression analysis. Osteoporos Int. 2017;28(10):2791–2800.
   PubMed Web of Science ®Google Scholar
• Ballane G, Cauley JA, Luckey MM, et al. Secular trends in hip fractures worldwide: opposing trends east versus west. J Bone Miner Res. 2014;29(8):1745–1755.
   PubMed Web of Science ®Google Scholar
• Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007;356(18):1809–1822.
   PubMed Web of Science ®Google Scholar
• Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) study group. JAMA. 1999;282(14):1344–1352.
   PubMed Web of Science ®Google Scholar
• Reginster J, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) study group. Osteoporos Int. 2000;11(1):83–91.
   PubMed Web of Science ®Google Scholar
• Liberman UA, Weiss SR, Broll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med. 1995;333(22):1437–1443.
   PubMed Web of Science ®Google Scholar
• Cummings SR, San Martin J, McClung MR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361(8):756–765.
   PubMed Web of Science ®Google Scholar
• Bone HG, Wagman RB, Brandi ML, et al. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol. 2017;5(7):513–523.
   PubMed Web of Science ®Google Scholar
• Miller PD, Hattersley G, Riis BJ, et al. Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial. JAMA. 2016;316(7):722–733.
   PubMed Web of Science ®Google Scholar
• Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344(19):1434–1441.
   PubMed Web of Science ®Google Scholar
• Finkelstein JS, Wyland JJ, Lee H, et al. Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis. J Clin Endocrinol Metab. 2010;95(4):1838–1845.
   PubMed Web of Science ®Google Scholar
• Cosman F, Crittenden DB, Adachi JD, et al. Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med. 2016;375(16):1532–1543.
   PubMed Web of Science ®Google Scholar
• Kendler DL, Marin F, Zerbini CAF, et al. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet. 2018;391(10117):230–240.
   PubMed Web of Science ®Google Scholar
• Saag KG, Petersen J, Brandi ML, et al. Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med. 2017;377(15):1417–1427.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Harvey NC, McCloskey E, et al. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos Int. 2020;31(1):1–12.
   PubMed Web of Science ®Google Scholar
• Lorentzon M. Treating osteoporosis to prevent fractures: current concepts and future developments. J Intern Med. 2019;285(4):381–394.
   PubMed Web of Science ®Google Scholar
• Solomon DH, Johnston SS, Boytsov NN, et al. Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011. J Bone Miner Res. 2014;29(9):1929–1937.
   PubMed Web of Science ®Google Scholar
• Lorentzon M, Nilsson AG, Johansson H, et al. Extensive undertreatment of osteoporosis in older Swedish women. Osteoporos Int. 2019;30(6):1297–1305.
   PubMed Web of Science ®Google Scholar
• Klotzbuecher CM, Ross PD, Landsman PB, et al. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000;15(4):721–739.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johnell O, De Laet C, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004;35(2):375–382.
   PubMed Web of Science ®Google Scholar
• Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture. JAMA. 2001;285(3):320–323.
   PubMed Web of Science ®Google Scholar
• Port L, Center J, Briffa NK, et al. Osteoporotic fracture: missed opportunity for intervention. Osteoporos Int. 2003;14(9):780–784.
   PubMed Web of Science ®Google Scholar
• van Geel TA, van Helden S, Geusens PP, et al. Clinical subsequent fractures cluster in time after first fractures. Ann Rheum Dis. 2009;68(1):99–102.
   PubMed Web of Science ®Google Scholar
• Johansson H, Siggeirsdottir K, Harvey NC, et al. Imminent risk of fracture after fracture. Osteoporos Int. 2017;28(3):775–780.
   PubMed Web of Science ®Google Scholar
• Osteoporosis Canada. Quality standards for fracture liaison services in Canada. Toronto: Osteoporosis Canada; 2014. Available from www.osteoporosis.ca.
   Google Scholar
• Osteoporosis New Zealand. Clinical Standards for Fracture Liaison Services in New Zealand. Wellington; 2016. Available from www.osteoporosis.org.nz.
   Google Scholar
• Gittoes N, McLellan A, Cooper A. Effective secondary prevention of fragility fractures: clinical standards for fracture liaison services. Camerton, UK: National Osteoporosis Society; 2015.
   Google Scholar
• Akesson K, Marsh D, Mitchell PJ, et al. Capture the fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle. Osteoporos Int. 2013;24(8):2135–2152.
   PubMed Web of Science ®Google Scholar
• Ganda K, Puech M, Chen JS, et al. Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int. 2013;24(2):393–406.
   PubMed Web of Science ®Google Scholar
• Wu CH, Tu ST, Chang YF, et al. Fracture liaison services improve outcomes of patients with osteoporosis-related fractures: a systematic literature review and meta-analysis. Bone. 2018;111:92–100.
   PubMed Web of Science ®Google Scholar
• Axelsson KF, Johansson H, Lundh D, et al. Association between recurrent fracture risk and implementation of fracture liaison services in four Swedish hospitals: a cohort study. J Bone Miner Res. 2020;35(7):1216–1223.
   PubMed Web of Science ®Google Scholar
• Gauthier A, Kanis JA, Martin M, et al. Development and validation of a disease model for postmenopausal osteoporosis. Osteoporos Int. 2011;22(3):771–780.
   PubMed Web of Science ®Google Scholar
• Cawston H, Maravic M, Fardellone P, et al. Epidemiological burden of postmenopausal osteoporosis in France from 2010 to 2020: estimations from a disease model. Arch Osteoporos. 2012;7:237–246.
   PubMedGoogle Scholar
• Axelsson KF, Nilsson AG, Wedel H, et al. Association between alendronate use and hip fracture risk in older patients using oral prednisolone. JAMA. 2017;318(2):146–155.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johansson H, Oden A, et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res. 2004;19(6):893–899.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johnell O, Oden A, et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int. 2005;16(2):155–162.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johansson H, Oden A, et al. A family history of fracture and fracture risk: a meta-analysis. Bone. 2004;35(5):1029–1037.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Harvey NC, Johansson H, et al. A decade of FRAX: how has it changed the management of osteoporosis? Aging Clin Exp Res. 2020;32(2):187–196.
   PubMed Web of Science ®Google Scholar
• Compston J, Bowring C, Cooper A, et al. Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas. 2013;75(4):392–396.
   PubMed Web of Science ®Google Scholar
• Cosman F, de Beur SJ, LeBoff MS, et al. Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359–2381.
   PubMed Web of Science ®Google Scholar
• Shepstone L, Lenaghan E, Cooper C, et al. Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet. 2018;391(10122):741–747.
   PubMed Web of Science ®Google Scholar
• Rubin KH, Rothmann MJ, Holmberg T, et al. Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study. Osteoporos Int. 2018;29(3):567–578.
   PubMed Web of Science ®Google Scholar
• Merlijn T, Swart KM, van Schoor NM, et al. The effect of a screening and treatment program for the prevention of fractures in older women: a randomized pragmatic trial. J Bone Miner Res. 2019;34(11):1993–2000.
   PubMed Web of Science ®Google Scholar
• Merlijn T, Swart KMA, van der Horst HE, et al. Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis. Osteoporos Int. 2020;31(2):251–257.
   PubMed Web of Science ®Google Scholar
• Kanis JA, McCloskey EV, Johansson H, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013;24(1):23–57.
   PubMed Web of Science ®Google Scholar